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Abstract Hematopoietic cell transplantation (HCT) is now
one of the frequent procedures used for treatment of malignant
and non-malignant blood diseases, autoimmune disorders,
and certain solid tumors. Despite improvements of therapeutic
protocols, HCTstill carries a high risk of non-relapse mortality
due to early and late complications. Side effects of the therapy
regimen frequently occur in the oral cavity and often signifi-
cantly decrease the patients’ quality of life. The complications
may result from or may be exacerbated by improper oral prep-
aration of the patient before transplantation. Therefore, it is
mandatory that all patients referred to HCT undergo thorough
dental examination and receive appropriate treatment before
the procedure. It is also very important to develop an individ-
ual post-transplantation oral care protocol with special con-
cerns to oral hygiene before implementation of the condition-
ing. This paper presents a review of dental management
methods intended for patients before HCT proposed in litera-
ture as well as recommendations based on the experience of
the Department of Comprehensive Dental Care and the
Department of Conservative Dentistry of Warsaw Medical
University and the Warsaw Institute of Hematology and
Blood Transfusion. The article pays special attention to the
problem of potential foci of infection and bleeding. It also
presents protocol of oral hygiene in post-transplantation
period, used by patients of Warsaw Medical University and
Institute of Hematology and Blood Transfusion.
Keywords Hematopietic cell transplantation . Pre-transplant
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Introduction
Hematopoietic cell transplantation (HCT) is now one of the
frequent procedures used for the treatment of malignant and
non-malignant blood diseases, autoimmune disorders, and
certain solid tumors [1]. According to the report of the
European Society for Blood and Marrow Transplantation,
there were 34,809 first-time transplants reported to the registry
in 2013. The number included 19,859 autologous transplants
(57%) and 14,950 (43%) allogeneic ones. Myeloablative con-
ditioning with or without TBI was used in 60% of the total
allogeneic HCT (allo-HCT) [2].
Despite improvements of therapeutic protocols, HCT still
carries a high risk of non-relapse mortality due to early and
late complications. Among those, infections play an important
role, especially in early post-transplantation period. These and
other complications are mostly related to allogeneic HCT,
which requires administration of immunosuppressive drugs
for several months and in some patients permanently. In addi-
tion to neutropenia and immunosuppressive treatment, specif-
ic complications like graft versus host disease (GvHD) con-
tribute to profound and long-lasting impairment of immunity.
Conditioning for autologus transplantation (auto-HCT) in-
duces only transient neutropenia and relatively mild alteration
of host defense. Severe mucosal injury after auto-HCTusually
resolves without long-term sequelae. Compared to allo-HCT,
in auto-HCT, the risk of delayed or persistent serious
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complications within the oral cavity, including infections, is
substantially lower [1].
In the oral cavity acute, delayed and late side effects of the
transplantation regimen affect approximately 80% of the pa-
tients [3–5]. In the early post-transplantation period, mucositis
resulting from conditioning is the main clinical symptom
which varies in degree and severity and depends primarily
on the intensity of conditioning regimen.
Damage of the oral mucosa together with profound myelo-
and immunosuppression after transplantation may lead to lo-
cal and systemic infections. Other side effects in the early
period may include bleeding due to thrombocytopenia as well
as pain, nutrition, and articulation impairment caused by mu-
cositis. In the first year after transplantation, oral cavity is
affected by delayed complications like hyposalivation, taste
disorders, and dentin hypersensitivity, which often important-
ly decrease the patients’ quality of life. Additionally, there still
remains a high risk of infection and bleeding in this period. At
later stages, long-term complications, fromwhich oral chronic
GvHD is the most important, may contribute to sicca syn-
drome, mastication impairment, malabsorption syndrome,
and lichen planus lesions in some cases. Also, other compli-
cations like advanced periodontal disease, rapid caries, and
taste disorders are common. It is significant to remember
about the risk of secondary cancers [6]. Although oral prob-
lems can compromise the treatment protocol and in some
cases affect the chance of survival, they are still
underestimated and undertreated [5, 6].
According to literature in line with clinical experience
and the authors’ own practice, oral complications may
result from or may be exacerbated by improper dental
preparation of the patient before transplantation and inad-
equate post-transplant oral care [7–9]. Therefore, all pa-
tients waiting for transplantation, definitely have to under-
go thorough dental examination and receive appropriate
treatment in adequate time before the procedure.
This paper presents a review of methods for dental
management of patients before HCT proposed in literature
as well as recommendations based on the experience of
authors of the publication.
General consideration regarding oral care protocol
before HCT
Detailed medical check-up before transplantation must in-
clude a thorough sanitation of oral cavity conducted by an
experienced dentist who should preferably be a permanent
member of the transplantation team [10, 11]. It is recommend-
ed that dental proceedings should include patient’s examina-
tion, establishment of treatment plan, execution of necessary
dental treatment, informing patient about possible side effects
of the therapy and delivery of oral hygiene instruction,
implementation of fluoride prophylaxis, and recommendation
of antibacterial oral rinses [6, 12].
Examination of the patient
The physical examination is carried out as normal. An
orthopanthomogram (OPG) of the maxilla and the mandible
is indispensible at the time of the first visit. Additional intra-
oral x-rays may be ordered if necessary [13, 14]. The dentist
should send a written dental report to the treating physician.
The optimal time for necessary dental procedures should be
specified in this paper.
Establishment of treatment plan and its limitations
Routine oral cavity pre-transplantation procedures should basi-
cally involve identification and elimination of active and poten-
tial foci of infection within the stomatognathic system and erad-
ication of local factors that may provoke trauma, pain, and
bleeding (Table 1) [3, 6]. Ideally, all existing and potential
sources of bleeding and/or pain should be eliminated before
the initiation of the conditioning. However, as indicated by our
experience, complete sanitation of oral cavity prior to transplan-
tation is not always achievable. The major elements that modify
oral treatment plan are the urgency of transplantation, patient’s
general health and remission status, peripheral blood counts,
nature and complexity of oral disease, patient’s financial re-
sources, motivation, and difficult access to dental services [24].
There is a lack of clearly defined oral treatment proto-
cols in the literature regarding indications to selected den-
tal procedures before HCT. This particularly concerns the
treatment of teeth with chronic pulpal/periodontal pathol-
ogy which can be a potential source of infection. The
most controversial question is: extraction or treatment?
Some authors suggest radical approach. They propose
the removal of all teeth with uncertain prognosis as the
only choice [6, 25]. Other studies, by contrast, recom-
mend minimally invasive pre-HCT dental treatment,
which means that in time constraints, acute pathologies
and non restorable teeth should be removed primarily
[15, 26–28]. It is emphasized that untreated chronic dental
pathologies do not have statistically important influence
on post-HCT infections. Tooth extraction is associated
with an increased risk of bleeding and also can attract
prolonged wound healing, a potential entry for infection
[29]. Toljanic et al. [26] conducted a prospective study on
patients undergoing chemotherapy and found that the con-
version of chronic dental disease to an acute state during
chemotherapy does not occur frequently. Yamagata et al.
[15] similarly observed that chronic dental pathologies
(including periapical radiolucencies less than 5 mm) that
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were left untreated before HCT do not significantly influ-
ence on the health status of HCT patients. This is in
agreement with the results found by Melkos et al. [27],
Peters et al. [28], and Schuurhuis et al. [30], who stated
that untreated chronic periapical foci did not affect the
incidence of infection during HCT.
In Warsaw Institute of Hematology and Blood
Transfusion, we recommend pre-HCT oral treatment plan
primarily determined by the time left for the procedure,
general health status of the patients, and toxicity of the
adopted conditioning regimen. On this basis, we qualify
the specific oral need (e.g., caries, periodontitis, poor oral
hygiene) as mandatory or optional. In order to achieve the
best results, evaluation should be performed even before
the recipient’s final medical check-up. If started early
enough, it may help to avoid unnecessary extractions
and influence the patient’s quality of life after transplan-
tation. It is preferable to complete all dental treatments at
least 2 weeks before the initiation of the conditioning [1,
6]. Unfortunately, the referral for HCT is often urgent due
to the compromised medical status of the patient. Also,
the initial dental examination often takes place very close
to the beginning of HCT procedure. In consequence, time
for oral treatment is limited [24]. If there is not enough
time to complete sanitation in a clinic, we recommend to
concentrate primarily on acute needs: eradication of active
infections (e.g., acute periodontal/periapical pathologies)
and elimination of potential sources of bleeding and/or
pain. Also, non-restorable teeth (i.e., exposed root tips)
should be extracted (Table 3, Appendix 1, 2). Elective
treatments can be addressed at the time when the patient
is in good condition. The toxicity of conditioning regimen
is also taken into consideration. The lower risk of general
and oral complications allows to reduce indications for
teeth extractions and to apply conservative treatment in-
stead. Extended indications for extractions are suggested
particularly in case of (1) high risk of early complications,
as a result of high-dose cytotoxic conditioning and ex-
pected aGvHD; (2) high risk of long-term complications,
especially in high risk of cGVHD; and (3) the patient’s
poor motivation for oral hygiene (Appendix 3). But, it has
to be mentioned that multiple extractions increase the risk
of bleeding, infection, delayed wound healing, and possi-
ble postponing of medical treatment [16, 27, 29]. We ob-
serve that they can also badly affect the long-term health
conditions and quality of life, because removal of many
teeth may compromise nutrition and have negative conse-
quences for occlusion and esthetic aspects as well.
Execution of dental procedures
The risk of bacteremia and sepsis is correlated primarily
with low neutrocyte count (ANC), but hematology pa-
tients even with normal ANC values should be considered
for antibiotic prophylaxis. Therefore, the treating physi-
cian should determine the need for such prophylaxis at
the time of referral for dental treatment [17, 35]. Unless
the hematologist proposes differently, recommendations
of the American Heart Association should be followed
(Table 2) [31].
Table 1 Potential foci of infection and local trauma/bleeding factors within the stomatognathic system in patients undergoing HCT [12, 15–23]
Focus of infection Advanced caries -Cavities in which excavation may lead to pulpal exposure,
-Cavities that can harbor fungal organisms,
-Unrestorable carious teeth,
-Compromised, large restorations
Moderate/advanced gingivitis and periodontitis - Furcation involvement greater than II grade,
-Advanced tooth mobility,
-Periodontal pockets ≥6 mm,
-Advanced recession (loss of two-third bone support)





-Root tips (not fully covered by bone or showing radiolucency),
-Cysts,
-Mucosal lesions,
-Leaking crowns and fillings
Local bleeding factors -Fractured teeth and/or restorations,
-Sharp edges of teeth and/or restorations,
-Ill-fitting dentures,
-Orthodontic appliances,
-Teeth contacting directly to the opposing mucosa
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Prophylactic platelet (PLT) transfusions are recom-
mended at PLT concentrations ≤30–40 × 109/L [13, 36].
In thrombocytopenic patients, local hemostatic measures
should be implemented apart from PLT transfusions.
Intra-alveolar dressings should be avoided (a potential
medium for bacterial growth), but sutures are recommend-
ed [35, 37]. It should be remembered that non-steroidal
anti-inflammatory drugs (NSAIDs) commonly used in
dentistry may increase risk of bleeding. In the case of
thrombocytopenia, medicaments without anti-aggregation
effect should be used (i.e., paracetamol, partial mixed
opiate receptor agonists, and mild opioids, such as oxy-
codone, hydroxycodone codeine, and tramadol) [38]. The
proposed procedures are presented in Appendix 1 and 2
and Table 3.
Oral hygiene instructions
Before initiation of conditioning, patients must be aware
of adverse effects of therapy which affect oral cavity. All
of them should be explained. Patients have to be
instructed about methods of preventing such complica-
tions and treatment. Oral hygiene practices must always
be adapted to individual needs of the patients and clinical
situation. The instruction is delivered both to the patients
and their caregivers (family, medical staff). In our clinic,
the recommendation are provided both orally and in writ-
ing and include information on teeth brushing (type of
toothpaste, toothbrushes, accessories such as floss, irriga-
tors), additional methods of topical fluoridation, oral mu-
cosa and lip care (including oral rinses), and the mainte-
nance of prosthetic restorations. Oral hygiene instructions
given to patients before the beginning of the transplanta-
tion in Warsaw Institute of Hematology and Blood
Transfusion are contained in Table 4.
Implementation of fluoride prophylaxis
Patients undergoing HCT, and especially allo-HCT, have a
high risk of developing caries. This is primarily due to
inadequate secretion of saliva, which affects more than
50% of patients in the post-transplant period [18]. Also,
mucositis and general clinical condition of the patient of-
ten preclude thorough teeth and oral cavity cleaning.
Therefore, in protocol developed in our institution, we
recommend introducing additional methods of dental hard
tissues remineralization well before transplantation proce-
dure. Fluoride prophylaxis follows the recommendations
Table 2 Antibiotic prophylaxis
before dental procedures
(according to the American Heart
Association 2007) [31]
60 min before the procedure
Orally Amoxicillin 2 g














Table 3 Recommendations of the minimally invasive dental treatment in a patient scheduled for HCT, based on the literature and the experience of the
authors [3, 13, 22, 24, 31–34]
Periodontal diseases -Removing of calculus and smoothing sharp edges of restorations, prosthetic restorations, and teeth,
-Extractions: teeth with periodontal pockets of 6 mm or deeper, teeth affected by endoperiodontic
complex with grades II and III furcations, markedly mobile (grade III mobility),
-Removing implants with pockets deeper than 6–7 mm
Impacted teeth -Removing teeth fully or partly erupted but only with signs of acute or chronic inflammation
Orthodontic treatment -Consider removing braces,
Orthodontic treatment can be continued within a year of HCT, if the patient is not on immunosuppression
Prosthetic treatment -Removing poor, permanent prosthetic replacements
Removable prosthetic restorations may continue to be worn depending on the mucous membrane
condition (mucositis, xerostomia) and the condition of the denture
Other procedures and recommendations -Reshaping or removing the teeth contacting opposing mucosa
-Treatment of parafunctions
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Table 4 Oral hygiene instructions intended for patients in Warsaw Institute of Hematology and Blood Transfusion and in the Department of Dentistry
of Warsaw Medical University
Before transplantation In the hospital After the hospital
Teeth Cleaning teeth: at least twice a day
(after every meal if possible).
Toothbrush: soft or medium, manual or
electric, replaced once a month.
Toothpaste: without lauryl sulfate.
If you do not have problems with gum
bleeding, use dental floss, dental
sticks, and irrigators.
Significant thrombocytopenia or if tooth brushing is
painful:
Clean with a sterile gauze and gentle antibacterial
solution without alcohol (as prescribed). Do not
use dental floss.
Without significant thrombocytopenia: clean at least
two times a day (after every meal and before night
is indicated). Use the super soft toothbrush,
replace once a week and a non-mint toothpaste
without lauryl sulfate. Initially, rinse out with
saline solution. After the healing of mucosal
changes, it is allowed to rinse with running water.
Use dental floss once a day.
Additional methods of dental care—as prescribed.
If there is the necessity of high-calorie food intake,
you have to pay special attention to systematic
oral care. It is recommended to avoid sugars and
use lactose-free ready-to-feed nutritional
products.
Cleaning teeth: at least twice a day (after every
meal and before night is recommended).
Toothbrush: soft or medium, manual or electric,
replace once a month.
Toothpaste: without lauryl sulfate or toothpaste
prescribed by the dentist. If you suffer from
dental hypersensitivity, use the toothpaste
dedicated to this problem. Rinse out with
running water.
Additional accessories: dental floss with fluoride,
dental sticks, interdental brushes, and
irrigators.
Additional home methods of caries protection
(necessary):
-Fluoride rinses without alcohol (at least weekly).
Keep it in mouth for 2–3 min, then spit.
or
-Fluoride gel (twice daily),
Do not rinse. Do not eat and drink for an hour
after fluoride application. If in doubt, ask the
dentist for advice.
During the first year after transplantation, it is
recommend to visit your dentist every 3 months
or more often if necessary.
Prosthesis Show the dentist your dental
prosthesis. Sometimes it will have to
be replaced with the new one.
Do not use the prosthesis in case of mucositis or use
it only during meals. Remove immediately after
every meal and clean it with toothbrush and
yellow soap. Soak for 1 hour in the antibacterial
solution recommended by your dentist. Then
wash the prosthesis carefully with the saline
solution. Keep it dry.
Use your prosthesis only to meals during the first
3 months after transplantation—especially
when mucosal changes exist.
Clean the prosthesis after every meal with soft
toothbrush and yellow soap. Soak for 1 hour in
the antibacterial solution recommended by
your dentist. Then, wash the prosthesis
carefully with running water. Keep it dry.
Remove your prosthesis overnight.
Remove the prosthesis before cleaning your own
teeth or rinsing the mouth.
In case of dryness, you can moisture the inner
surface of the prosthesis with an artificial
saliva.
Oral mucosa Rinsing the mouth: twice a day with
chlorhexidine solution: 0.2%
(10 ml) or 0.12% (18 ml). You can
dilute the liquid with boiled water
(1:1). Start rinsing at least 7 day
before the beginning of
chemo/radiotherapy.
Keep 1 hour distance between
irrigation with the chlorhexidine
solution and:
-Washing your teeth,




-Saline solution (every 3 h) or
-Baking soda solution (1 teaspoon diluted in 250-ml
slightly warm boiled water, every 3 h).
In case of severe dryness, use additional rinses (as
prescribed, e.g., artificial saliva).
Avoid mouthwashes containing alcohol, citric acid,
and glycerol.
Cleaning the tongue: soft toothbrush or gauze with
saline or baking soda solutions.
Your doctor can order rinsing your mouth with
antifungal agents. Remember:
-To remove your prosthesis before rinsing,
-Not to eat, drink, wash your teeth, or use other
medical remedies for at least an hour after the
application.
You can lubricate the inner surface of the prosthesis
with the antifungal medicament.
Other recommendations:
-Chew your food gently,
-Rinse your mouth after vomiting,
-Avoid abnormal behaviors (e.g., biting the oral
mucosa with the teeth),
-Avoid coffee, tobacco, sweetened drinks (cola,
juices, tea), and sweet, sticky foods, dried spices.
In case of oral dryness:
Stimulating the saliva secretion:
-Chewing gum without sugar (for example with
xylitol),
-Candies without sugar,
-A piece of frozen fresh pineapple or canned
pineapple but rinsed carefully with water first.
Do not use the pineapple in case of mucositis.
Moisturizing the mouth:
-Frequent sipping of still water, keeping in the
mouth for a while. You can add few drops of
fresh lime juice,
-Moisturizing agents (oral balance, caphosol,
artificial saliva), 4–10 times a day,
-Rinsing with infusion of linseed,
-Air humidification at home.
Lips Use vaseline, allantoin, or vitamin A
ointments.
Clean with the gauze with gentle disinfectants (e.g.,
baking soda). Take special care of your mouth
corners!
Use vaseline, allantoin, or vitamin A ointments.
Use vaseline, allantoin, or vitamin A ointments.
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of the American Dental Association (ADA) dedicated for
patients 6 years or older being at an elevated risk of dental
caries. The protocol includes professionally applied topi-
cal fluoride agents: (1) 2.26% fluoride varnish (at least
every 3–6 months) or (2) 1.23% fluoride (APF) gel for
4 min (at least every 3–6 months) and prescription-
strength, home-use measures: (1) a prescription-strength,
home-use 0.5% fluoride gel or paste (twice daily) or (2)
0.09% fluoride mouthrinse (at least weekly) [39]. Non-
mint-flavored toothpaste with fluoride but free from sodi-
um lauryl sulfate, which may irritate oral soft tissues, is
recommended. Fluoride varnishes should be avoided in
case of irritation of the mucosa [6, 40].
Recommendation of antibacterial oral rinses
Because of an increased risk of oral infections, introduc-
tion of local antimicrobial solutions is suggested. Our pa-
tients start using mouthwash measures 7–14 days prior to
the conditioning. Alcohol-free rinses with 0.12–0.2%
chlorhexidine digluconate solution are advisable. The pa-
tients should remember to make at least an hour break
between the application of antibacterial rinses and tooth
brushing or use of locally acting antifungal suspensions
(nystatin, amphotericin) [6].
Discussion
It is a widely recognized fact that general oral health of
most patients undergoing HCT is not satisfactory and re-
flects the status in the societies they come from. Although
some of the acute oral disorders resulting from the ther-
apy may be reduced, in many cases, they remain unavoid-
able. Also, the significant impact of long-term complica-
tions may negatively affect patient’s quality of life.
Therefore, this unique group of patients requires in-
creased awareness and recognition to promote the appro-
priate oral prophylaxis and care. Unfortunately, not all
patients undergo specialist dental examination at the
pre-HCT stage [19, 41]. According to Barker [32], only
40% of the patients receive this type of examination.
Also, there are few algorithms of dental management
based on reliable clinical studies targeted at adult patients
undergoing transplantation [3, 5, 6, 42]. Available proto-
cols based on standards of individual transplant centers
are sometimes contradictory and imprecise. Various au-
thors differ in their opinions especially when it comes
to defining potential foci of infection within the
stomatognathic system, and whether it is mandatory for
them to be eliminated before conditioning chemo/
radiotherapy is commenced. Some of them are in favor
of radical oral sanitation and recommend removal of all
existing and potential sources of infection [8, 16, 43–46].
Eradicating all active and potential foci of infection may
significantly lower the risk of local and systemic compli-
cations associated with immunosuppression (from 40 to
12%) [16]. Other authors however are in favor of limited,
minimally invasive dental treatment before HCT [15, 24].
They refer to disadvantageous aspects of radical ap-
proach, as it may delay treatment of the underlying dis-
ease. It is emphasized that invasive procedures in itself
carry a risk of infection and increases the risk of
prolonged bleeding [15, 47]. Moreover, radical sanitation
often means extraction of teeth that otherwise would be
conservatively treated, thus, harming the patient [28].
Missing teeth may contribute to alimentary disorders,
since wearing prosthetic restorations following transplant
is often problematic.
Before initiation of conditioning regimen, the patient
must be made aware of adverse effects of the therapy
which affect oral cavity; they also have to be instructed
in methods of their prevention and treatment. According
to reports in literature, only 30% of the recipients are
given this kind of information prior to HCT [48].
Detailed oral hygiene instructions delivered to the patients
and their caregivers are an important part of dental pre-
HCT treatment. The patients should be motivated to begin
appropriate hygiene regimen several weeks before trans-
plantation, as it may alleviate potential oral cavity com-
plications during and after transplantation. At pre-
transplant stage, the patients should also be advised of
the necessity of frequent dental check-ups, especially in
the first year after the transplant procedure.
Conclusion
Patients undergoing hematopoietic stem cell transplantation
often suffer from oral ailments that are a consequence of the
basic illness or therapy. These complicationsmay compromise
health or even be life-threatening during HCT. Adequate den-
tal treatment may decrease this risk. So far, there are no com-
monly accepted protocols of dental examination and treatment
of patients before HCT. Each transplant center should design
and implement a dental care protocol based on available liter-
ature and own clinical experience. For best results, experi-
enced dental practitioners must be permanently included in
transplantation teams.
Compliance with ethical standards




Possible protocol for minimally invasive treatment of
caries/non carious lesions in adult patients prior to HCT,
based on the literature and the experience of the authors
(considering the severity of lesion, time for completing
the dental treatment, and the medical status of the patient)
[3, 15, 22, 26, 36, 46, 47, 49, 50].
1. Criteria for caries progression [3, 26, 51]:
& Initial caries lesion: limited to the enamel or ce-
mentum or very outermost layer of dentin on the
root surface
& Moderate caries lesion: visible signs of enamel break-
down, the dentin is moderately demineralised, shal-
low cavitation
& Advanced caries lesion: dentin is exposed, deep
cavitation: without symptoms of irreversible
pulpitis (clinical/radiographic examination) or
with symptoms of irreversible pulpitis (clinical/ra-
diographic examination)
2. Non-carious lesion: the lesion of dental hard tissues of
non cariogenic origin (attritions, erosions, abfractions,
abrasions)
3. The assessment of time for dental treatment before the
conditioning regimen:
& Sufficient time for completing the procedure: the
final dental procedure can be successfully termi-
nated (e.g., root canal therapy with permanent ob-
turation). The risk of local/general complications
of the treatment is taken into consideration. No
endodontic treatment unless patient has 7 days
from the completion of endodontic therapy to on-
s e t o f mye l o s u pp r e s s i o n ( <1 000–2000
granulocytes/mm3, 3, 27]
& Insufficient time left for competing the proce-
dure: the final dental procedure cannot be suc-
cessfully terminated, or there are acute needs to
be cured first. The risk of local/general compli-
ca t i ons o f t he t r e a tmen t i s t aken in to
consideration
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4. Risk of dental treatment, concerning general health status
of the pre-HCT patient:
& High risk patient: neutropenic and/or thrombocytope-
nic patient,
& Moderate risk patient: myelosuppression/ immuno-
suppression due to chemotherapy,
& Low risk patient: no evidence of malignancy and
myelosuppression [9, 20]
5. ART (atraumatic restorative treatment): the approach that
involves the use of hand instruments only to remove car-
ious tooth substance and then restoring the cavity and
sealing any adjacent enamel fissures with a glass ionomer
restorative cement (GIC) [49]
Appendix 2
The protocol of minimally invasive treatment proposed for
pulpal/periapical lesions in patients prior to HCT considering
the severity of pulpal pathology, time for completing end-
odontic treatment, and the medical status of the patient [3,
22, 26, 35, 36, 46, 47]
1. The assessment of time for dental treatment before the
conditioning regimen:
Sufficient time for completing the procedure: the final
dental procedure can be successfully terminated (e.g., root
canal therapy with permanent obturation). The risk of
local/general complications of the treatment is taken into
consideration. No endodontic treatment unless patient has
7 days from the completion of endodontic therapy to onset
of myelosuppression (<1000–2000 granulocytes/mm3, 3,
27]
Insufficient time left for competing the procedure: the
final dental procedure cannot be successfully terminated,
or there are acute needs to be cured first. The risk of local/
general complications of the treatment is taken into
consideration.
2. Risk of dental treatment, concerning general health status
of the pre-HCT patient:
High risk patient: neutropenic and/or thrombocytope-
nic patient,
Modera te r i sk pa t i en t : mye losuppress ion/
immunosuppression due to chemotherapy,




The protocol of minimally invasive treatment for pulpal/
periapical lesions in patients prior to HCTconsidering the risk
of oral and general complications as a result of the toxicity of
the conditioning proposed byWarsaw Institute of Hematology
and Blood Transfusion.
1. Moderate risk of complications in case of reduced in-
tensity conditioning
2. High risk of complications in case of high-dose cytotoxic
conditioning, high risk of long-term complications, espe-
cially in high risk of GVHD.
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